These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2894287)

  • 1. The clinical usefulness of agonist-antagonist analgesics in acute pain.
    Rosow CE
    Drug Alcohol Depend; 1987 Dec; 20(4):329-37. PubMed ID: 2894287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit-risk ratio of agonist-antagonist analgesics.
    Lasagna L
    Drug Alcohol Depend; 1987 Dec; 20(4):385-93. PubMed ID: 2894291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical usefulness of agonist-antagonistic opioid analgesics in chronic pain.
    Hanks GW
    Drug Alcohol Depend; 1987 Dec; 20(4):339-46. PubMed ID: 2894288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Full µ-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence.
    van Niel JC; Schneider J; Tzschentke TM
    Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects and analgesic efficacy of the agonist-antagonist opioids.
    Zola EM; McLeod DC
    Drug Intell Clin Pharm; 1983 Jun; 17(6):411-7. PubMed ID: 6861632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid agonist/antagonists in general anaesthesia.
    Wilkinson DJ
    Br J Hosp Med; 1987 Aug; 38(2):130-3. PubMed ID: 2888499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using mixed agonist-antagonists.
    D'Arcy Y
    Nursing; 2005 Feb; 35(2):17. PubMed ID: 15706252
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical observations of agonist-antagonist analgesic dependence.
    Peachey JE
    Drug Alcohol Depend; 1987 Dec; 20(4):347-65. PubMed ID: 2894289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia.
    Bowdle TA
    Drug Saf; 1998 Sep; 19(3):173-89. PubMed ID: 9747665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of current pharmacologic treatment of pain].
    Brasseur L
    Drugs; 1997; 53 Suppl 2():10-7. PubMed ID: 9190320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in analgesia: a randomized trial of mu versus kappa opioid agonists.
    Miller PL; Ernst AA
    South Med J; 2004 Jan; 97(1):35-41. PubMed ID: 14746420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy.
    Errick JK; Heel RC
    Drugs; 1983 Sep; 26(3):191-211. PubMed ID: 6137354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which potent opioid? Important criteria for selection.
    Bovill JG
    Drugs; 1987 May; 33(5):520-30. PubMed ID: 2954811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans.
    Gear RW; Gordon NC; Miaskowski C; Paul SM; Heller PH; Levine JD
    Neurosci Lett; 2003 Nov; 351(1):5-8. PubMed ID: 14550900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone versus nalbuphine infusion for prophylaxis of epidural morphine-induced pruritus.
    Kendrick WD; Woods AM; Daly MY; Birch RF; DiFazio C
    Anesth Analg; 1996 Mar; 82(3):641-7. PubMed ID: 8623975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-analgesic effects of opioids: opioid-induced respiratory depression.
    Boom M; Niesters M; Sarton E; Aarts L; Smith TW; Dahan A
    Curr Pharm Des; 2012; 18(37):5994-6004. PubMed ID: 22747535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.